Steve N. Slilaty Ph.D.
Net Worth
Last updated:
What is Steve N. Slilaty Ph.D. net worth?
The estimated net worth of Dr. Steve N. Slilaty Ph.D. is at least $2,473,475 as of 8 Feb 2024. He owns shares worth $42,900 as insider, has earned $129,575 from insider trading and has received compensation worth at least $2,301,000 in Sunshine Biopharma, Inc..
What is the salary of Steve N. Slilaty Ph.D.?
Dr. Steve N. Slilaty Ph.D. salary is $177,000 per year as Chairman, Chief Executive Officer & Pres in Sunshine Biopharma, Inc..
How old is Steve N. Slilaty Ph.D.?
Dr. Steve N. Slilaty Ph.D. is 73 years old, born in 1952.
What stocks does Steve N. Slilaty Ph.D. currently own?
As insider, Dr. Steve N. Slilaty Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Sunshine Biopharma, Inc. (SBFM) | Chairman, Chief Executive Officer & Pres | 30,000 | $1.43 | $42,900 |
What does Sunshine Biopharma, Inc. do?
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.
Steve N. Slilaty Ph.D. insider trading
Sunshine Biopharma, Inc.
Dr. Steve N. Slilaty Ph.D. has made only one insider trade between 2012-2024, according to the Form 4 filled with the SEC. He purchased 20,000 units of SBFM stock worth $2,000 on 8 Feb 2024.
As of 8 Feb 2024 he still owns at least 30,000 units of SBFM stock.
Sunshine Biopharma key executives
Sunshine Biopharma, Inc. executives and other stock owners filed with the SEC:
- Dr. Abderrazzak Merzouki (61) Chief Operating Officer & Director
- Dr. Steve N. Slilaty Ph.D. (73) Chairman, Chief Executive Officer & Pres
- Mr. Camille Sebaaly (66) Chief Financial Officer & Sec.